<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2019</study_start_year><data_sharing_plan>IPD Sharing (as of July 2023): Undecided</data_sharing_plan><condition>Ovarian Cancer</condition><condition>Squamous Cell Carcinoma of Head and Neck</condition><condition>Carcinoma</condition><condition>Head and Neck Squamous Cell Carcinoma</condition><condition>Colorectal Cancer</condition><condition>Non-small Cell Lung Cancer</condition><condition>Prostate Cancer</condition><condition>Urothelial Carcinoma</condition><condition>Breast Cancer</condition><disease>Ovarian Cancer</disease><disease>Squamous Cell Carcinoma Of Head And Neck</disease><disease>Carcinoma</disease><disease>Non-small Cell Lung Cancer</disease><disease>Colorectal Cancer</disease><disease>Urothelial Carcinoma</disease><disease>Prostate Cancer</disease><disease>Head And Neck Squamous Cell Carcinoma</disease><disease>Breast Cancer</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2289098</full_dataset_link><location>United States</location><study_start_month>8</study_start_month><repository>ECRIN MDR</repository><study_status>Completed</study_status></additional><is_claimable>false</is_claimable><name>A Study to Evaluate ONM-100, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer</name><description>This study is to evaluate diagnostic performance, safety and timing of post-dose imaging of ONM-100, an intraoperative fluorescence imaging agent for the detection of cancer in patients with solid tumors undergoing routine surgery.</description><dates><creation>2019-08-15</creation></dates><accession>2289098</accession><cross_references><ClinicalTrials___gov>NCT03735680</ClinicalTrials___gov></cross_references></HashMap>